Amikacin Sulfate Patent Expiration
Amikacin Sulfate is used for treating Mycobacterium Avium Complex (MAC) lung disease in adults as part of a combination drug regimen. It was first introduced by Apothecon Inc Div Bristol Myers Squibb
Amikacin Sulfate Patents
Given below is the list of patents protecting Amikacin Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Arikayce Kit | US10251900 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US10751355 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US11446318 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US12016873 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US12168021 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US12168022 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US9895385 | Methods for treating pulmonary non-tuberculous mycobacterial infections | May 15, 2035 | Insmed Inc |
| Arikayce Kit | US9566234 | Systems for treating pulmonary infections | Jan 18, 2034 | Insmed Inc |
| Arikayce Kit | US8226975 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Aug 15, 2028 | Insmed Inc |
| Arikayce Kit | US8632804 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Dec 05, 2026 | Insmed Inc |
| Arikayce Kit | US8642075 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Dec 05, 2026 | Insmed Inc |
| Arikayce Kit | US8679532 | Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof | Dec 05, 2026 | Insmed Inc |
| Arikayce Kit | US7718189 | Sustained release of antiinfectives | Jun 06, 2025 | Insmed Inc |
| Arikayce Kit | US8802137 | Sustained release of antiinfectives |
Apr 08, 2024
(Expired) | Insmed Inc |
| Arikayce Kit | US9827317 | Sustained release of antiinfectives |
Apr 08, 2024
(Expired) | Insmed Inc |
Amikacin Sulfate's Family Patents
Explore Our Curated Drug Screens
Amikacin Sulfate Generic API Manufacturers
Several generic applications have been filed for Amikacin Sulfate. The first generic version for Amikacin Sulfate was by Apothecon Inc Div Bristol Myers Squibb and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Qilu Pharmaceutical Co Ltd and was approved on Mar 19, 2024.
Given below is the list of companies who have filed for Amikacin Sulfate generic, along with the locations of their manufacturing plants worldwide.
1. ABBOTT
Abbott Laboratories has filed for 1 generic for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Abbott.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Nov 30, 1994 |
Manufacturing Plant Locations New
Abbott's manufacturing plants are situated in 7 countries - United States, Netherlands, United Kingdom, Norway, Germany, France, Ireland. Given below are the details of these plant locations as well as the firm names of Abbott as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Netherlands |
| |||||||||||||
| United Kingdom |
| |||||||||||||
| Norway |
| |||||||||||||
| Germany |
| |||||||||||||
| France |
| |||||||||||||
| Ireland |
| |||||||||||||
2. APOTHECON
Apothecon Inc Div Bristol Myers Squibb has filed for 2 different strengths of generic version for Amikacin Sulfate. All of these versions come by the name AMIKIN. Given below are the details of the strengths of this generic introduced by Apothecon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 50MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Sep 20, 1984 |
| EQ 250MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Sep 20, 1984 |
Manufacturing Plant Locations New
Apothecon's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Apothecon as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. AVET LIFESCIENCES
Avet Lifesciences Ltd has filed for 1 generic for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Avet Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML
(reference standard) | injectable | Prescription | INJECTION | AP | Dec 12, 2013 |
4. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Prescription | INJECTION | AP | Dec 9, 2015 |
| EQ 50MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Dec 9, 2015 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
5. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Prescription | INJECTION | AP | Apr 11, 1994 |
| EQ 50MG BASE/ML
(reference standard) | injectable | Prescription | INJECTION | N/A | Apr 11, 1994 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
6. HOSPIRA
Hospira Worldwide, Inc has filed for 4 different strengths of generic version for Amikacin Sulfate. Out of these eq 500mg base/100ml version comes by the name AMIKACIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Jun 26, 1995 |
| EQ 50MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Nov 30, 1994 |
| EQ 62.5MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Oct 31, 1994 |
| EQ 500MG BASE/100ML | injectable | Discontinued | INJECTION | N/A | Apr 2, 1997 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
7. IGI LABS INC
Igi Laboratories Inc has filed for 2 different strengths of generic version for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Igi Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Dec 14, 1995 |
| EQ 50MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Dec 14, 1995 |
8. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Prescription | INJECTION | AP | Sep 28, 1993 |
| EQ 50MG BASE/ML | injectable | Discontinued | INJECTION | N/A | Sep 28, 1993 |
9. QILU
Qilu Pharmaceutical Co Ltd has filed for 1 generic for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Qilu.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Prescription | INJECTION | AP | Mar 19, 2024 |
Manufacturing Plant Locations New
Qilu's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Qilu as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China |
| |||||||||||||||
10. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 1 generic for Amikacin Sulfate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 250MG BASE/ML | injectable | Prescription | INJECTION | AP | May 12, 2016 |